These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 23522528

  • 1. Movement disorders in multiple sclerosis and other demyelinating diseases.
    Mehanna R, Jankovic J.
    J Neurol Sci; 2013 May 15; 328(1-2):1-8. PubMed ID: 23522528
    [Abstract] [Full Text] [Related]

  • 2. Movement Disorders in Multiple Sclerosis: An Update.
    Ghosh R, Roy D, Dubey S, Das S, Benito-León J.
    Tremor Other Hyperkinet Mov (N Y); 2022 May 15; 12():14. PubMed ID: 35601204
    [Abstract] [Full Text] [Related]

  • 3. Movement disorders in multiple sclerosis and neuromyelitis optica: A clinical marker of neurological disability.
    Candeias da Silva C, Bichuetti DB, Azevedo Silva SMC, Ferraz HB, Oliveira EML, Borges V.
    Parkinsonism Relat Disord; 2018 Jun 15; 51():73-78. PubMed ID: 29530725
    [Abstract] [Full Text] [Related]

  • 4. Movement disorders in multiple sclerosis: Causal or coincidental association?
    Nociti V, Bentivoglio AR, Frisullo G, Fasano A, Soleti F, Iorio R, Loria G, Patanella AK, Marti A, Tartaglione T, Tonali PA, Batocchi AP.
    Mult Scler; 2008 Nov 15; 14(9):1284-7. PubMed ID: 18768580
    [Abstract] [Full Text] [Related]

  • 5. Movement disorders in patients with multiple sclerosis.
    Shneyder N, Harris MK, Minagar A.
    Handb Clin Neurol; 2011 Nov 15; 100():307-14. PubMed ID: 21496590
    [Abstract] [Full Text] [Related]

  • 6. Movement disorders in multiple sclerosis.
    Tranchant C, Bhatia KP, Marsden CD.
    Mov Disord; 1995 Jul 15; 10(4):418-23. PubMed ID: 7565820
    [Abstract] [Full Text] [Related]

  • 7. Movement disorders in multiple sclerosis.
    Oakes PK, Srivatsal SR, Davis MY, Samii A.
    Phys Med Rehabil Clin N Am; 2013 Nov 15; 24(4):639-51. PubMed ID: 24314682
    [Abstract] [Full Text] [Related]

  • 8. Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature.
    Potulska-Chromik A, Rudzinska M, Nojszewska M, Podlecka-Piętowska A, Szczudlik A, Zakrzewska-Pniewska B, Gołębiowski M.
    Folia Neuropathol; 2014 Nov 15; 52(1):92-100. PubMed ID: 24729346
    [Abstract] [Full Text] [Related]

  • 9. [Comparative analysis of clinical and neurophysiological indices in patients with multiple sclerosis and acute demyelinating polyneuropathy].
    Nikitina VV, Skoromets AA, Barbas IM, Iantareva LI, Pospelova ML.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004 Nov 15; 104(3):52-4. PubMed ID: 15071845
    [Abstract] [Full Text] [Related]

  • 10. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
    Wingerchuk DM, Lucchinetti CF.
    Curr Opin Neurol; 2007 Jun 15; 20(3):343-50. PubMed ID: 17495631
    [Abstract] [Full Text] [Related]

  • 11. Osmotic demyelination syndrome with two-phase movement disorders: case report.
    Chuang YC, Chang CS, Hsu SP, Lin TK, Lui CC.
    Changgeng Yi Xue Za Zhi; 1998 Dec 15; 21(4):526-30. PubMed ID: 10074746
    [Abstract] [Full Text] [Related]

  • 12. Pathology of demyelinating diseases.
    Popescu BF, Lucchinetti CF.
    Annu Rev Pathol; 2012 Dec 15; 7():185-217. PubMed ID: 22313379
    [Abstract] [Full Text] [Related]

  • 13. Pathological differences in acute inflammatory demyelinating diseases of the central nervous system.
    Wegner C.
    Int MS J; 2005 Apr 15; 12(1):13-9, 12. PubMed ID: 15955274
    [Abstract] [Full Text] [Related]

  • 14. Movement disorders in a cohort of Algerian patients with multiple sclerosis.
    Hatteb SA, Daoudi S.
    Rev Neurol (Paris); 2018 Mar 15; 174(3):167-172. PubMed ID: 29153981
    [Abstract] [Full Text] [Related]

  • 15. Chapter 33: the history of movement disorders.
    Lanska DJ.
    Handb Clin Neurol; 2010 Mar 15; 95():501-46. PubMed ID: 19892136
    [Abstract] [Full Text] [Related]

  • 16. Atypical inflammatory demyelinating syndromes of the CNS.
    Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG.
    Lancet Neurol; 2016 Aug 15; 15(9):967-981. PubMed ID: 27478954
    [Abstract] [Full Text] [Related]

  • 17. Classification and diagnostic criteria for demyelinating diseases of the central nervous system: Where do we stand today?
    Mathey G, Michaud M, Pittion-Vouyovitch S, Debouverie M.
    Rev Neurol (Paris); 2018 Jun 15; 174(6):378-390. PubMed ID: 29673575
    [Abstract] [Full Text] [Related]

  • 18. Phenomenological patterns and aetiological spectrum in patients visiting a tertiary care Movement disorders service in India: An observational study.
    Kumar N, Desai I, Kumar M, Singh J, Tiwari A, Dhar N, Madhaw G, Manchanda R, Jatale V, Radhakrishnan DM, Warrier AR, Shree R, Kumari S.
    Clin Neurol Neurosurg; 2024 Oct 15; 245():108492. PubMed ID: 39146723
    [Abstract] [Full Text] [Related]

  • 19. [Relationship of opticomyelitis and diffuse sclerosis].
    Marchenkova RL, Komandenko NI, Skoromets AA.
    Sov Med; 1978 Jul 15; (7):63-7. PubMed ID: 694578
    [No Abstract] [Full Text] [Related]

  • 20. Ocular manifestations in demyelinating diseases.
    François J.
    Adv Ophthalmol; 1979 Jul 15; 39():1-36. PubMed ID: 532756
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.